Adorno-Cruz Valery, Kibria Golam, Liu Xia, Doherty Mary, Junk Damian J, Guan Dongyin, Hubert Chris, Venere Monica, Mulkearns-Hubert Erin, Sinyuk Maksim, Alvarado Alvaro, Caplan Arnold I, Rich Jeremy, Gerson Stanton L, Lathia Justin, Liu Huiping
Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Department of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Cancer Res. 2015 Mar 15;75(6):924-9. doi: 10.1158/0008-5472.CAN-14-3225. Epub 2015 Jan 20.
With the goal to remove the roots of cancer, eliminate metastatic seeds, and overcome therapy resistance, the 2014 inaugural International Cancer Stem Cell (CSC) Conference at Cleveland, OH, convened together over 320 investigators, including 55 invited world-class speakers, 25 short oral presenters, and 100 poster presenters, to gain an in-depth understanding of CSCs and explore therapeutic opportunities targeting CSCs. The meeting enabled intriguing discussions on several topics including: genetics and epigenetics; cancer origin and evolution; microenvironment and exosomes; metabolism and inflammation; metastasis and therapy resistance; single cell and heterogeneity; plasticity and reprogramming; as well as other new concepts. Reports of clinical trials targeting CSCs emphasized the urgent need for strategically designing combinational CSC-targeting therapies against cancer.
为了根除癌症根源、清除转移种子并克服治疗抗性,2014年首届国际癌症干细胞(CSC)会议在俄亥俄州克利夫兰召开,汇聚了320多名研究人员,其中包括55位受邀的世界级演讲者、25位短报告口头演讲者和100位海报展示者,旨在深入了解癌症干细胞并探索针对癌症干细胞的治疗机会。会议就多个主题展开了引人入胜的讨论,包括:遗传学和表观遗传学;癌症起源与进化;微环境与外泌体;代谢与炎症;转移与治疗抗性;单细胞与异质性;可塑性与重编程;以及其他新概念。针对癌症干细胞的临床试验报告强调了迫切需要从战略上设计针对癌症的联合癌症干细胞靶向疗法。